Compare Nuvalent Inc (NUVL) vs Suncor Energy Inc. (SU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvalent Inc vs Suncor Energy Inc. — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Suncor Energy Inc. trades at $63.7 (market cap $72.86B). The key difference: Suncor Energy Inc. is far larger — about 7.4× Nuvalent Inc's market cap, and Suncor Energy Inc. pays a 2.71% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | SU | |
|---|---|---|
Market Cap | $9.81B | $72.86B |
Sector | Technology | Energy |
52-Week High | $123.96 | $69.73 |
52-Week Low | $72.16 | $38.17 |
Enterprise Value | $8.52B | $80.99B |
Dividend Yield | — | 2.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nuvalent (NUVL) trades at $123.96, showing no change recently, with technical indicators presenting a mixed signal—moving averages are bullish while oscillators are bearish. The company reported a net loss of $425.38 million for 2025, with negative profitability metrics like ROE of -41.19%. Recent news highlights GSK's proposed acquisition of Nuvalent for $124 per share, totaling $10.6 billion, which is under investigation by multiple law firms for fairness concerns.
The investment outlook is heavily influenced by the pending acquisition, offering a near-term exit at $124 per share. However, risks include ongoing financial losses, negative cash flow from operations, and legal scrutiny over the deal's adequacy. Analyst sentiment is mixed with 42% buy ratings, but the acquisition provides a clear valuation anchor amid fundamental challenges.
Suncor Energy (SU) trades at $63.70, up 2.03% today, with a bullish technical signal from moving averages. The company reported mixed Q1 2026 earnings, missing EPS estimates, but beat in the prior two quarters. Valuation ratios appear reasonable with a P/E of 16.8 and EV/EBITDA of 7.08. Strong profitability is evident with a net income margin of 11.62% and ROE of 13.97%. A dividend of $0.60 per share is scheduled for payment on June 25, 2026.
The outlook for SU is supported by record production and integrated operations, but faces risks from oil price volatility and operational incidents. Analyst consensus is strongly bullish with 74% buy ratings. The stock's performance hinges on upcoming Q2 2026 results and broader energy market trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →
